Showing results (121-130 of 151) with videos related to

Sort By:
Pageof 16
The Journal of Allergy and Clinical Immunology|December 23, 2018
Evaluation of clinical benefit from treatment with mepolizumab for patients with eosinophilic granulomatosis with polyangiitisJonathan Steinfeld, Eric S Bradford, Judith Brown, et al.
EULAR Rheumatology Open|June 29, 2026
Patients' perspectives of eosinophilic granulomatosis with polyangiitis within the context of a clinical trialPeter A Merkel, Bernhard Hellmich, Christian Pagnoux, et al.
The New England Journal of Medicine|May 18, 2017
Mepolizumab or Placebo for Eosinophilic Granulomatosis with PolyangiitisMichael E Wechsler, Praveen Akuthota, David Jayne, et al.
The Journal of Rheumatology|December 7, 2005
Current status of outcome measures in vasculitis: focus on Wegener's granulomatosis and microscopic polyangiitis. Report from OMERACT 7Peter A Merkel, Philip Seo, Peter Aries, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|August 4, 2021
Mepolizumab for Eosinophilic Granulomatosis With Polyangiitis: A European Multicenter Observational StudyAlessandra Bettiol, Maria Letizia Urban, Lorenzo Dagna, et al.
Autoimmunity Reviews|January 7, 2022
Management of nonviral mixed cryoglobulinemia vasculitis refractory to rituximab: Data from a European collaborative study and review of the literatureClara Pouchelon, Marcella Visentini, Giacomo Emmi, et al.
The New England Journal of Medicine|April 2, 2025
A Phase 3 Trial of Upadacitinib for Giant-Cell ArteritisDaniel Blockmans, Sara K Penn, Arathi R Setty, et al.
Nature Reviews. Rheumatology|October 16, 2025
Challenges in the diagnosis, classification and prognosis of ANCA-associated vasculitisMarta Casal Moura, Peter A Merkel, David Jayne, et al.
BMC Rheumatology|July 31, 2021
The Joint Vasculitis Registry in German-speaking countries (GeVas) - a prospective, multicenter registry for the follow-up of long-term outcomes in vasculitisChristof Iking-Konert, Pia Wallmeier, Sabrina Arnold, et al.
The Journal of Rheumatology|June 7, 2007
The future of damage assessment in vasculitisPhilip Seo, Raashid A Luqmani, Oliver Flossmann, et al.
Pageof 16